BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mangia A, Cenderello G, Verucchi G, Ciancio A, Fontana A, Piazzolla V, Minerva N, Squillante MM, Copetti M. Is positivity for hepatitis C virus antibody predictive of lower risk of death in COVID-19 patients with cirrhosis? World J Clin Cases 2020; 8(22): 5831-5834 [PMID: 33344581 DOI: 10.12998/wjcc.v8.i22.5831]
URL: https://www.wjgnet.com/1948-5182/full/v8/i22/5831.htm
Number Citing Articles
Noa Krawczyk, Bianca D. Rivera, Cale Basaraba, Thomas Corbeil, Bennett Allen, Katharina Schultebraucks, Brandy F. Henry, Harold A. Pincus, Frances R. Levin, Diana Martinez. COVID‐19 complications among patients with opioid use disorder: a retrospective cohort study across five major NYC hospital systemsAddiction 2023;  doi: 10.1111/add.16105
Shimaa Afify, Basem Eysa, Fatma Abdel Hamid, Omnia M Abo-Elazm, Mohamed A Edris, Rabab Maher, Ahmed Abdelhalim, Muhammad Mostafa Abdel Ghaffar, Dalia A Omran, Hend Ibrahim Shousha. Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective studyWorld Journal of Gastroenterology 2021; 27(42): 7362-7375 doi: 10.3748/wjg.v27.i42.7362
Fares E M Ali, Zuhair M Mohammedsaleh, Mahmoud M Ali, Osama M Ghogar. Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challengesWorld Journal of Gastroenterology 2021; 27(15): 1531-1552 doi: 10.3748/wjg.v27.i15.1531
Viola Guardigni, Elena Rosselli Del Turco, Lorenzo Badia, Silvia Galli, Kristian Scolz, Pierluigi Viale, Gabriella Verucchi. Pre-Existing HBV and HCV Infections Do Not Affect COVID-19-Related Outcomes: An Observational Retrospective StudyHepatitis Monthly 2021; 21(5) doi: 10.5812/hepatmon.116986
Xinyu Hu, Longyan Sun, Zhaoyang Guo, Chao Wu, Xin Yu, Jie Li. Management of COVID-19 patients with chronic liver diseases and liver transplantsAnnals of Hepatology 2022; 27(1): 100653 doi: 10.1016/j.aohep.2021.100653
NitinA John, JyotiE John. Implication of COVID-19 in patients of HIV with hepatitis CJournal of Family Medicine and Primary Care 2022; 11(3): 828 doi: 10.4103/jfmpc.jfmpc_1090_21
David L. Fisher , Stephen Malnick. Liver and COVID-19 - A Review and Clinical ApproachCoronaviruses 2022; 3(1) doi: 10.2174/2666796702666211005142343
Paul Middleton, Catherine Hsu, Mark P Lythgoe. Clinical outcomes in COVID-19 and cirrhosis: a systematic review and meta-analysis of observational studiesBMJ Open Gastroenterology 2021; 8(1): e000739 doi: 10.1136/bmjgast-2021-000739
Taghreed S Saeed Al-Rawi, Raid M Al-Ani. Liver dysfunction-related COVID-19: A narrative reviewWorld Journal of Meta-Analysis 2023; 11(1): 5-17 doi: 10.13105/wjma.v11.i1.5
Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal DiseasesFrontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.753249
Nevio Cimolai. The Complexity of Co-Infections in the Era of COVID-19SN Comprehensive Clinical Medicine 2021; 3(7): 1502 doi: 10.1007/s42399-021-00913-4
Essamedin M. Negm. Does mass management of chronic hepatitis C protect the Egyptian population against fulminant coronavirus disease-2019? “Postulating a hypothesis”The Egyptian Journal of Bronchology 2022; 16(1) doi: 10.1186/s43168-022-00120-2
Manuela G. Neuman, Helmut K. Seitz, Rolf Teschke, Stephen Malnick, Kamisha L. Johnson-Davis, Lawrence B. Cohen, Anit German, Nicolas Hohmann, Bernhardo Moreira, George Moussa, Mihai Opris. Molecular, Viral and Clinical Features of Alcohol- and Non-Alcohol-Induced Liver InjuryCurrent Issues in Molecular Biology 2022; 44(3): 1294 doi: 10.3390/cimb44030087